MEDPLANT is a manufacturing company specializing in the production of wide range of modern portable innovative import-substituting medical equipment for first aid and emergency medicine (arterial bleeding control, cardiopulmonary resuscitation, monitoring of life-threatening conditions, transport immobilization, evacuation and transportation of patients). Company has 34 registered medical devices and 15 invention patents. The company possesses ISO 13485, ISO 9001 certificates and a range of products was granted with European CE certificates. Over 20 000 ambulances in all regions of Russia and neighboring countries are equipped with products manufactured by MEDPLANT company, the devices are also widely used by the Ministry of Emergency Situations, emergency medicine and the Armed Forces of the Russian Federation.


The R&D center is designed for the development and pilot production of innovative drugs. It comprises a complex of R&D laboratories and production sites with technological capabilities unique for the Russian pharmaceutical industry. The center’s facilities allow to carry out 15-20 R&D projects and produce up to 80 m product units per year. Apart from the development of its own drug portfolio, NovaMedica Innotech cooperates with foreign and local partners to fulfill their orders for drug development and manufacture of small wholesale batches. NovaMedica Innotech is a subsidiary of NovaMedica company - a RUSNANO project.


The company specializes in the development and manufacturing of original photosensitiser based on chlorophyll, development of the photodynamic therapy and fluorescent diagnostics method.


Founded in 1993, the ELTA company is an acknowledged leader on the Russian medical equipment market. The company’s mission is to make hi-tech medical production available for everyone.
The company is unique in being the first to develop and produce express blood glucose meters in Russia. It is also one of the few Russian manufacturers whose production is based wholly on original inventions.
The company organizes and manages most of the production stages by its own means, from molding plastic parts to producing control materials, all at it’s own production facilities.


The company specializes in full-cycle production and assembly of unique medical devices in the field of infection control systems in health care: steam autoclaves; low temperature plasma sterilizers, medical waste sterilization plants, disinfection cleaning machines. In terms of performance parameters, these medical devices excel among similar well-known devices from leading manufacturers.


BIOCAD is a fully integrated biotechnology company with in-house capabilities from new molecules discovery to large-scale commercial manufacturing and marketing. The company has its own world-class R&D centers, pharmaceutical and biotech manufacturing sites and performs non-clinical and clinical studies, all in compliance with the international industry standards.
Company portfolio includes more than 50 approved products, 10 of which are biologics. There are over 40 products in development: biologics, small molecules, gene and cell therapy drugs. Today BIOCAD is focused on developing original drugs—next-in-class and first-in-class—for immuno-oncology, hematology and autoimmune disease treatment.
BIOCAD has 8 international offices and subsidiaries. Company products are already marketed in 21 countries from Latin America to Africa and South East Asia and approval processes are ongoing in over 30 countries worldwide. Starting from 2021 the company will launch its original and biosimilar products in Europe and plans to enter Chinese market in 2022.


A leader in the field of manufacturing treatment-and-prophylactic and multi-functional sport nutrition. The company has been conducting research in the field of biotechnology and threpsology for over 20 years and supplying with the Russian National Team, including many world champions and champions of the Sochi-2014 Olympic Winter Games sports and clinical nutrition. None of the company’s products contain any component subjected to genetic modification, doping substances or their metabolites.

Bright Way Industries

Bright Way Industries LLC is incorporated into actively developing BRIGHT WAY Group of Companies that successfully implemented 2 investment projects for the last 6 years – construction of a pharmaceutical / logistics center in the Moscow Region and startup of an up-to-date pharmaceutical plant in Kurgan city. The total volume of investments exceeded 3 billion Russian roubles.
In 2018 Bright Way Industries LLC commenced implementing a business project for establishing a pharmaceutical plant in the Special Economic Zone TECHNOPOLIS MOSCOW (Zelenograd town, Alabushevo site).
The business areas of priority for Bright Way Industries LLC are as follows:

  • production of finished pharmaceutical products belonging to various pharmacotherapeutic groups and pharmaceutical forms of presentation;
  • implementation of new projects with foreign business partners for the purpose of localization of required pharmaceutical preparations in the territory of the Russian Federation;
  • organization of transfer of new manufacturing technologies and co-operation in research and innovative development work.
    Bright Way Industries LLC is planning to arrange for distribution of products in both the Russian market and the market of the countries of near and far abroad.
    The estimated value of this project is over 2.5 billion Russian roubles.

Since 2001, the Orthomoda design center has been developing and manufacturing orthopedic footwear. In 2009, it started producing specialized (adaptive) clothing for disabled people. Most of the developments are intended for children. Special attention is paid to practicality and appearance of the clothing and footwear for disabled people. In 2017, a new innovative orthopedic footwear production site was launched at Technopolis “Moscow”. Currently, the company is developing the following areas:

  • its own network of Orthomoda orthopedic shoe shops, providing consulting and diagnostic services;
  • wholesale supplies of Orthomoda orthopedic footwear and adaptive clothing to all regions of Russia and neighboring countries;
  • e-shop for Orthomoda orthopedic footwear and clothing;
  • Government Contracts Department (production and supply of orthopedic footwear);
  • individual orders for designer orthopedic shoes, insoles and clothing. A synergy of knowledge and expertise of the Technopolis residents enables the development of digital technologies.

Russian-based company Inkoro, LLC develops and manufactures medical products. At the moment the company is producing devices for urology such as ureteral stents and ureteral catheters in sets and in different designs. The company is constantly expanding the product range. The production line of medical devices is based upon technology created by Rocamed company (Monaco) which guarantees high European quality tested by time.


Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.


The company is a manufacturer of medical equipment, anesthetic machines, and lung ventilators in Russia. It also provides maintenance and repair services for medical equipment and runs training programs for specialists.
Founded in 1935, CHIRANA, a well-known European medtech manufacturer, today is one of the leaders on the market in Eastern Europe. One of the main activities of the company is anesthesiology and resuscitation science. It is widely known that the most technology-dependant area in medicine is medical emergency treatment and anesthesiology. Due to active cooperation between the company and employees of medical facilities in Slovakia, today the needs of medical practitioners and the technical capabilities of the manufacturer are in balance.
Preserving the traditions allows the company to store and refresh experience in medtech manufacturing in order to save lives.


The company was established in 2005. Its portfolio includes products for production animals and pets — vaccines, diagnostic systems, anti-parasitic, antibacterial and disinfecting agents. The company has major experience in manufacturing for federal state procurement. Its products have been registered in the Russian Federation and beyond, in Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, and Ukraine and are sold in all these countries. It has over 140 employees, with 30 of them in possession of a master’s or PhD degree. The company has advanced hi-tech equipment. Development, manufacturing and product quality control comply with the Good Manufacturing Practice. Vetbiochem LLC quality management system complies with the requirements of GOST ISO 9001-2011. Proprietary technologies are used in the production process. The company plans to expand and revamp its current facilities, develop new technologies including those which help decrease product costs, and expand the range of products that substitute imported ones, and so it is creating and equipping new production areas and R&D departments which comply with international and domestic industrial standards.


Official manufacturer of equipment for medical gas supply in the Russian Federation. Key activities of MZ Liberec RUS LLC include development and revamping of existing models, design, manufacturing, sales and maintenance of pressure monitoring systems, end elements of gas main lines i. e. wall-mounted consoles in wards, and bridge and ceiling-mounted gas supply complexes for surgery and intensive care rooms. Its products are developed and manufactured to satisfy individual requirements of its clients in different configurations and in compliance with applicable Russian regulations.


Development of production technology and the production of modern drugs, including modified-release drugs and combination drugs belonging to different pharmacological groups and various drug forms.

Acrus BioMed

Aсrus BioMed is engaged in the development and manufacturing of biomedical cell products (BMCP). One of the pioneers of the new industry, it brings together the most qualified specialists. First-line products include BMCP for the treatment of nonhealing wounds, ulcers and extensive burns, allowing to restore the skin in a short time and without scars. Acrus BioMed cooperates with the leading R&D centers. The company's pipe-line features new BMСPs for the treatment of various socially significant diseases. Universal manufacturing equipment makes it possible to organize contract production of other BMCP of the different composition and purpose as well as their components. The registration process is currently in progress and products will be available for use in 2021.


The aim of the company is to manufacture high-quality medical equipment for stomated patients, which can compete on equal grounds and even surpass their foreign counterparts, and provide the patients with accessible high-quality medical and rehabilitation technology.
The founding company of GemaTech is Gemamed LLC, which has been on the Russian medical equipment market for over 10 years. Gemamed has earned its reputation as a reliable and trustworthy supplier of drugs, medical equipment and high-quality assistive appliances for stomated patients (for gastro-intestinal and urogenital pathologies, skincare and wound treatment.)


LasMedTech is one of the world leaders in laser technology. The company has an extensive structure featuring R&D labs that employ specialists with outstanding expertise in the development, manufacturing and implementation of advanced laser systems.
LasMedTech produces a wide variety of laser units, emitters, and applicators for esthetic medicine, minimally invasive therapy, surgery and stomatology.
The company has its own medical base. Its machines have all international certification and are widely used in medical facilities around the world.


Mesoformula company produces innovative products for aesthetic medicine and professional cosmetology.
The company rapidly grows, constantly extending the range of products, improving the composition of preparations and using the latest scientific developments in the field of aesthetic medicine. It allows Mesoformula to take a leading position on the Russian market of mesotherapy, providing products under the brand Mesopharm™.
In production the company uses only high-quality and safe ingredients of the world's leading suppliers.
A wide range of products is based on market needs: preparations for mesotherapy and rejuvenation based on hyaluronic acid, peptide complexes, chemical peels, professional cosmetics.

Provectus biotech

A state-of-art R&D biotechnology company that develops pharmaceutical products produced by the recombinant DNA biotechnology method using eukaryotic and prokaryotic cells in compliance with Russian / EAEU and European requirements for pharmaceutical products. The drugs being developed are among the latest in modern medicinбe and are used to treat diseases related to oncology, autoimmune, cardiovascular and infectious diseases, inflammatory reactions of various origins, systemic sclerosis, and other diseases.
The company has all the necessary laboratory equipment for working with producer cell lines, upstream and downstream process development, as well as a number of physicochemical and biological methods of analysis necessary for assessing the quality and control of developed products.


Development and production of oncology medical products.


Development and production of psychoneurological medical products.


R-Opra, LLC signed a contract with Moscow authorities that aims to increase the availability of certain medicines (some of which are not yet being produced in Russia) for patients in the Russian capital. These include drugs used for treatment of cardiologic, oncological, psychiatric, respiratory diseases, multiple sclerosis and chronic kidney failure. For the purposes of the agreement a new manufacturing facility will be constructed in SEZ Technopolis Moscow in Zelenograd.